Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 510

1.

Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis.

Janssen QP, Buettner S, Suker M, Beumer BR, Addeo P, Bachellier P, Bahary N, Bekaii-Saab T, Bali MA, Besselink MG, Boone BA, Chau I, Clarke S, Dillhoff M, El-Rayes BF, Frakes JM, Grose D, Hosein PJ, Jamieson NB, Javed AA, Khan K, Kim KP, Kim SC, Kim SS, Ko AH, Lacy J, Margonis GA, McCarter MD, McKay CJ, Mellon EA, Moorcraft SY, Okada KI, Paniccia A, Parikh PJ, Peters NA, Rabl H, Samra J, Tinchon C, van Tienhoven G, van Veldhuisen E, Wang-Gillam A, Weiss MJ, Wilmink JW, Yamaue H, Homs MYV, van Eijck CHJ, Katz MHG, Koerkamp BG.

J Natl Cancer Inst. 2019 May 14. pii: djz073. doi: 10.1093/jnci/djz073. [Epub ahead of print]

PMID:
31086963
2.

Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experience.

Bhutani MS, Cazacu IM, Luzuriaga Chavez AA, Singh BS, Wong FCL, Erwin WD, Tamm EP, Mathew GG, Le DB, Koay EJ, Taniguchi CM, Minsky BD, Pant S, Tzeng CD, Koong AC, Varadhachary GR, Katz MHG, Wolff RA, Fogelman DR, Herman JM.

VideoGIE. 2019 Apr 29;4(5):223-225. doi: 10.1016/j.vgie.2019.02.009. eCollection 2019 May. No abstract available.

3.

Association between frailty syndrome and survival in patients with pancreatic adenocarcinoma.

Ngo-Huang A, Holmes HM, des Bordes JKA, Parker NH, Fogelman D, Petzel MQB, Song J, Bruera E, Katz MHG.

Cancer Med. 2019 Apr 29. doi: 10.1002/cam4.2157. [Epub ahead of print]

4.

EMTALA-A Noble Policy That Needs Improvement.

Katz MH, Wei EK.

JAMA Intern Med. 2019 Apr 1. doi: 10.1001/jamainternmed.2019.0026. [Epub ahead of print] No abstract available.

PMID:
30933215
5.

Supplemental Security Income and the Health of Low-Income Adults.

DeJong C, Katz MH.

JAMA Intern Med. 2019 Apr 1. doi: 10.1001/jamainternmed.2019.0058. [Epub ahead of print] No abstract available.

PMID:
30933212
6.

ASO Author Reflections: Temporary Mesocaval Shunt: Indications and Technique for Safe Resection of Pancreatic Tumors With Mesenteric Venous Occlusion.

Simoneau E, Katz MH, Lee JE, Tzeng CD.

Ann Surg Oncol. 2019 Mar 11. doi: 10.1245/s10434-019-07290-2. [Epub ahead of print] No abstract available.

PMID:
30859352
7.

Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline.

Shroff RT, Kennedy EB, Bachini M, Bekaii-Saab T, Crane C, Edeline J, El-Khoueiry A, Feng M, Katz MHG, Primrose J, Soares HP, Valle J, Maithel SK.

J Clin Oncol. 2019 Apr 20;37(12):1015-1027. doi: 10.1200/JCO.18.02178. Epub 2019 Mar 11.

PMID:
30856044
8.

Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection.

Prakash LR, Wang H, Zhao J, Nogueras-Gonzalez GM, Cloyd JM, Tzeng CD, Kim MP, Lee JE, Katz MHG.

J Gastrointest Surg. 2019 Feb 28. doi: 10.1007/s11605-019-04126-y. [Epub ahead of print]

PMID:
30820801
9.

Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencing.

Lee AJ, Simoneau E, Chiang YJ, Lee JE, Kim MP, Aloia TA, Vauthey JN, Katz MH, Tzeng CD.

HPB (Oxford). 2019 Feb 21. pii: S1365-182X(19)30066-8. doi: 10.1016/j.hpb.2019.01.011. [Epub ahead of print]

PMID:
30799277
10.

Expression and Clinical Significance of Protein Kinase RNA-Like Endoplasmic Reticulum Kinase and Phosphorylated Eukaryotic Initiation Factor 2α in Pancreatic Ductal Adenocarcinoma.

Wang EM, Akasaka H, Zhao J, Varadhachary GR, Lee JE, Maitra A, Fleming JB, Hung MC, Wang H, Katz MHG.

Pancreas. 2019 Mar;48(3):323-328. doi: 10.1097/MPA.0000000000001248.

PMID:
30747823
11.

Perioperative Therapy for Borderline Resectable Pancreatic Cancer: What and When?

Kim MP, Katz MHG.

Ann Surg Oncol. 2019 Jun;26(6):1596-1597. doi: 10.1245/s10434-019-07177-2. Epub 2019 Jan 24. No abstract available.

PMID:
30680479
12.

Borderline resectable pancreatic cancer-At the crossroads of precision medicine.

Katz MHG, Varadhachary GR.

Cancer. 2019 May 15;125(10):1584-1587. doi: 10.1002/cncr.31936. Epub 2019 Jan 23. No abstract available.

PMID:
30673119
13.

Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity.

Capello M, Vykoukal JV, Katayama H, Bantis LE, Wang H, Kundnani DL, Aguilar-Bonavides C, Aguilar M, Tripathi SC, Dhillon DS, Momin AA, Peters H, Katz MH, Alvarez H, Bernard V, Ferri-Borgogno S, Brand R, Adler DG, Firpo MA, Mulvihill SJ, Molldrem JJ, Feng Z, Taguchi A, Maitra A, Hanash SM.

Nat Commun. 2019 Jan 16;10(1):254. doi: 10.1038/s41467-018-08109-6.

14.

Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer.

Blando J, Sharma A, Higa MG, Zhao H, Vence L, Yadav SS, Kim J, Sepulveda AM, Sharp M, Maitra A, Wargo J, Tetzlaff M, Broaddus R, Katz MHG, Varadhachary GR, Overman M, Wang H, Yee C, Bernatchez C, Iacobuzio-Donahue C, Basu S, Allison JP, Sharma P.

Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1692-1697. doi: 10.1073/pnas.1811067116. Epub 2019 Jan 11.

PMID:
30635425
15.

Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted Analysis.

Cloyd JM, Chen HC, Wang X, Tzeng CD, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG.

Pancreas. 2019 Feb;48(2):216-222. doi: 10.1097/MPA.0000000000001231.

PMID:
30629022
16.

Retail Clinics Provide Important Antibiotic Stewardship-Reply.

Redberg RF, Incze M, Katz MH.

JAMA Intern Med. 2019 Jan 1;179(1):124. doi: 10.1001/jamainternmed.2018.7013. No abstract available.

PMID:
30615086
17.

Chemoresistance Transmission via Exosome-Mediated EphA2 Transfer in Pancreatic Cancer.

Fan J, Wei Q, Koay EJ, Liu Y, Ning B, Bernard PW, Zhang N, Han H, Katz MH, Zhao Z, Hu Y.

Theranostics. 2018 Nov 13;8(21):5986-5994. doi: 10.7150/thno.26650. eCollection 2018.

18.

Contemporary analysis of complications associated with biliary stents during neoadjuvant therapy for pancreatic adenocarcinoma.

Kim BJ, Prakash L, Narula N, Davis CH, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MH, Tzeng CD.

HPB (Oxford). 2018 Dec 3. pii: S1365-182X(18)34506-4. doi: 10.1016/j.hpb.2018.10.009. [Epub ahead of print]

PMID:
30522947
19.

Improving Outcomes After Distal Pancreatectomy with Celiac Axis Resection (DP-CAR): As Always, it is All About Patient Selection.

Ikoma N, Katz MHG.

Ann Surg Oncol. 2019 Mar;26(3):703-704. doi: 10.1245/s10434-018-07104-x. Epub 2018 Dec 11. No abstract available.

PMID:
30539493
20.

Pancreaticoduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic Adenocarcinoma.

Simoneau E, Goumard C, Lee JE, Vauthey JN, Aloia TA, Chun YS, Kim MP, Katz MHG, Tzeng CD.

Ann Surg Oncol. 2019 Feb;26(2):652. doi: 10.1245/s10434-018-07093-x. Epub 2018 Dec 11.

PMID:
30539487
21.

Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Identification of clinical targets for optimization.

Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CD.

HPB (Oxford). 2018 Nov 27. pii: S1365-182X(18)34525-8. doi: 10.1016/j.hpb.2018.10.018. [Epub ahead of print]

PMID:
30501986
22.

Clinical Factors Associated With Practice Variation in Discharge Opioid Prescriptions After Pancreatectomy.

Newhook TE, Vreeland TJ, Dewhurst WL, Wang X, Prakash L, Feng C, Bruno ML, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CD.

Ann Surg. 2018 Nov 29. doi: 10.1097/SLA.0000000000003112. [Epub ahead of print]

PMID:
30499795
23.

Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression.

Bernard V, Semaan A, Huang J, San Lucas FA, Mulu FC, Stephens BM, Guerrero PA, Huang Y, Zhao J, Kamyabi N, Sen S, Scheet PA, Taniguchi CM, Kim MP, Tzeng CW, Katz MH, Singhi AD, Maitra A, Alvarez HA.

Clin Cancer Res. 2019 Apr 1;25(7):2194-2205. doi: 10.1158/1078-0432.CCR-18-1955. Epub 2018 Nov 1.

PMID:
30385653
24.

Regulating the Dietary Supplement Industry: The Taming of the Slew.

Incze M, Katz MH.

JAMA Intern Med. 2018 Dec 1;178(12):1723. doi: 10.1001/jamainternmed.2018.5097. No abstract available.

PMID:
30357259
25.

Physical activity and exercise during preoperative pancreatic cancer treatment.

Parker NH, Ngo-Huang A, Lee RE, O'Connor DP, Basen-Engquist KM, Petzel MQB, Wang X, Xiao L, Fogelman DR, Schadler KL, Simpson RJ, Fleming JB, Lee JE, Varadhachary GR, Sahai SK, Katz MHG.

Support Care Cancer. 2019 Jun;27(6):2275-2284. doi: 10.1007/s00520-018-4493-6. Epub 2018 Oct 17.

PMID:
30334105
26.

Decreased Admission Rate From the Emergency Department With Increased Emergency Department Visits-The Good and the Bad.

Katz MH.

JAMA Intern Med. 2018 Dec 1;178(12):1710-1711. doi: 10.1001/jamainternmed.2018.5163. No abstract available.

PMID:
30326003
27.

First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma.

Gulhati P, Prakash L, Katz MHG, Wang X, Javle M, Shroff R, Fogelman D, Lee JE, Tzeng CD, Lee JH, Weston B, Tamm E, Bhosale P, Koay EJ, Maitra A, Wang H, Wolff RA, Varadhachary GR.

Ann Surg Oncol. 2019 Feb;26(2):619-627. doi: 10.1245/s10434-018-6807-9. Epub 2018 Oct 15.

PMID:
30324485
28.

The "Public Charge" Proposal and Public Health: Implications for Patients and Clinicians.

Katz MH, Chokshi DA.

JAMA. 2018 Nov 27;320(20):2075-2076. doi: 10.1001/jama.2018.16391. No abstract available.

PMID:
30285073
29.

Nephrostomy tube placement prior to percutaneous nephrolithotomy does not impact outcomes.

Bearelly P, Lis C, Trussler J, Katz MH, Babayan RK, Wang DS.

Can J Urol. 2018 Oct;25(5):9497-9502.

PMID:
30281007
30.

High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer.

Bannon SA, Montiel MF, Goldstein JB, Dong W, Mork ME, Borras E, Hasanov M, Varadhachary GR, Maitra A, Katz MH, Feng L, Futreal A, Fogelman DR, Vilar E, McAllister F.

Cancer Prev Res (Phila). 2018 Nov;11(11):679-686. doi: 10.1158/1940-6207.CAPR-18-0014. Epub 2018 Oct 1.

PMID:
30274973
31.

The role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinoma.

Cloyd JM, Prakash L, Vauthey JN, Aloia TA, Chun YS, Tzeng CW, Kim MP, Lee JE, Katz MHG.

Am J Surg. 2018 Sep 6. pii: S0002-9610(18)30811-0. doi: 10.1016/j.amjsurg.2018.08.024. [Epub ahead of print]

PMID:
30224070
32.

Medicaid Work Requirements-English Poor Law Revisited.

Chokshi DA, Katz MH.

JAMA Intern Med. 2018 Nov 1;178(11):1555-1557. doi: 10.1001/jamainternmed.2018.4193. No abstract available.

PMID:
30208385
33.

A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma.

Koay EJ, Lee Y, Cristini V, Lowengrub JS, Kang Y, Lucas FAS, Hobbs BP, Ye R, Elganainy D, Almahariq M, Amer AM, Chatterjee D, Yan H, Park PC, Rios Perez MV, Li D, Garg N, Reiss KA, Yu S, Chauhan A, Zaid M, Nikzad N, Wolff RA, Javle M, Varadhachary GR, Shroff RT, Das P, Lee JE, Ferrari M, Maitra A, Taniguchi CM, Kim MP, Crane CH, Katz MH, Wang H, Bhosale P, Tamm EP, Fleming JB.

Clin Cancer Res. 2018 Dec 1;24(23):5883-5894. doi: 10.1158/1078-0432.CCR-17-3668. Epub 2018 Aug 6.

PMID:
30082477
34.

Death Among the Unsheltered Homeless: Hidden in Plain Sight.

Incze M, Katz MH.

JAMA Intern Med. 2018 Sep 1;178(9):1248-1249. doi: 10.1001/jamainternmed.2018.2919. No abstract available.

PMID:
30073317
35.

Use of Limited Transthoracic Echocardiogram: Nothing More, Nothing Less.

Katz MH.

JAMA Intern Med. 2018 Sep 1;178(9):1272. doi: 10.1001/jamainternmed.2018.3483. No abstract available.

PMID:
30039156
36.

Overprescription in Urgent Care Clinics-The Fast and the Spurious.

Incze MA, Redberg RF, Katz MH.

JAMA Intern Med. 2018 Sep 1;178(9):1269-1270. doi: 10.1001/jamainternmed.2018.1628. No abstract available.

PMID:
30014130
37.

Risk-stratified clinical pathways decrease the duration of hospitalization and costs of perioperative care after pancreatectomy.

Denbo JW, Bruno M, Dewhurst W, Kim MP, Tzeng CW, Aloia TA, Soliz J, Speer BB, Lee JE, Katz MHG.

Surgery. 2018 Sep;164(3):424-431. doi: 10.1016/j.surg.2018.04.014. Epub 2018 May 25.

PMID:
29807648
38.

Vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Patency rates and outcomes associated with thrombosis.

Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CD.

J Surg Oncol. 2018 Jun;117(8):1648-1654. doi: 10.1002/jso.25067. Epub 2018 May 3.

PMID:
29723419
39.

Medical Care for Undocumented Immigrants-Reply.

Saadi A, Ahmed S, Katz MH.

JAMA. 2018 Apr 24;319(16):1727-1728. doi: 10.1001/jama.2018.1373. No abstract available.

PMID:
29710157
40.

Preoperative Chemoradiation for Borderline Resectable Pancreatic Cancer: The New Standard?

Katz MH, Kim MP, Tzeng CW, Lee JE.

Ann Surg. 2018 Aug;268(2):223-224. doi: 10.1097/SLA.0000000000002783. No abstract available.

41.

Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases.

Cloyd JM, Omichi K, Mizuno T, Kawaguchi Y, Tzeng CD, Conrad C, Chun YS, Aloia TA, Katz MHG, Lee JE, Halperin D, Yao J, Vauthey JN, Dasari A.

Ann Surg Oncol. 2018 Jun;25(6):1709-1715. doi: 10.1245/s10434-018-6468-8. Epub 2018 Apr 6.

PMID:
29626307
42.

Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer.

Wang YN, Lee HH, Chou CK, Yang WH, Wei Y, Chen CT, Yao J, Hsu JL, Zhu C, Ying H, Ye Y, Wang WJ, Lim SO, Xia W, Ko HW, Liu X, Liu CG, Wu X, Wang H, Li D, Prakash LR, Katz MH, Kang Y, Kim M, Fleming JB, Fogelman D, Javle M, Maitra A, Hung MC.

Cancer Cell. 2018 Apr 9;33(4):752-769.e8. doi: 10.1016/j.ccell.2018.02.012. Epub 2018 Mar 29.

43.

Patient-derived xenograft cryopreservation and reanimation outcomes are dependent on cryoprotectant type.

Ivanics T, Bergquist JR, Liu G, Kim MP, Kang Y, Katz MH, Perez MVR, Thomas RM, Fleming JB, Truty MJ.

Lab Invest. 2018 Jul;98(7):947-956. doi: 10.1038/s41374-018-0042-7. Epub 2018 Mar 8.

44.

Significance of T1a and T1b Carcinoma Arising in Mucinous Cystic Neoplasm of Pancreas.

Hui L, Rashid A, Foo WC, Katz MH, Chatterjee D, Wang H, Fleming JB, Tamm EP, Wang H.

Am J Surg Pathol. 2018 May;42(5):578-586. doi: 10.1097/PAS.0000000000001040.

45.

Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy.

Amer AM, Zaid M, Chaudhury B, Elganainy D, Lee Y, Wilke CT, Cloyd J, Wang H, Maitra A, Wolff RA, Varadhachary G, Overman MJ, Lee JE, Fleming JB, Tzeng CW, Katz MH, Holliday EB, Krishnan S, Minsky BD, Herman JM, Taniguchi CM, Das P, Crane CH, Le O, Bhosale P, Tamm EP, Koay EJ.

Cancer. 2018 Apr 15;124(8):1701-1709. doi: 10.1002/cncr.31251. Epub 2018 Jan 25.

46.

Comparing Postoperative Complications and Inflammatory Markers Using Total Intravenous Anesthesia Versus Volatile Gas Anesthesia for Pancreatic Cancer Surgery.

Soliz JM, Ifeanyi IC, Katz MH, Wilks J, Cata JP, McHugh T, Fleming JB, Feng L, Rahlfs T, Bruno M, Gottumukkala V.

Anesth Pain Med. 2017 Aug 21;7(4):e13879. doi: 10.5812/aapm.13879. eCollection 2017 Aug.

47.

Should Fear of Adverse Events Influence the Decision to Administer Preoperative Therapy to Patients with Pancreatic Cancer?

Katz MHG.

Ann Surg Oncol. 2018 Mar;25(3):588-590. doi: 10.1245/s10434-017-6302-8. Epub 2017 Dec 14. No abstract available.

PMID:
29243201
48.

Anthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and Pancreatoduodenectomy.

Cloyd JM, Nogueras-González GM, Prakash LR, Petzel MQB, Parker NH, Ngo-Huang AT, Fogelman D, Denbo JW, Garg N, Kim MP, Lee JE, Tzeng CD, Fleming JB, Katz MHG.

J Gastrointest Surg. 2018 Apr;22(4):703-712. doi: 10.1007/s11605-017-3618-4. Epub 2017 Dec 11.

49.

Imaging findings of recurrent pancreatic cancer following resection.

Javadi S, Karbasian N, Bhosale P, de Castro Faria S, Le O, Katz MH, Koay EJ, Tamm EP.

Abdom Radiol (NY). 2018 Feb;43(2):489-496. doi: 10.1007/s00261-017-1397-8.

PMID:
29198001
50.

International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017.

Isaji S, Mizuno S, Windsor JA, Bassi C, Fernández-Del Castillo C, Hackert T, Hayasaki A, Katz MHG, Kim SW, Kishiwada M, Kitagawa H, Michalski CW, Wolfgang CL.

Pancreatology. 2018 Jan;18(1):2-11. doi: 10.1016/j.pan.2017.11.011. Epub 2017 Nov 22.

Supplemental Content

Support Center